• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Ultrasound . Early detection of deep vein thrombosis in patients with coronavirus disease 2019: who to screen and who not to with Doppler ultraso

tetano

Editor, Senior Moderator
J Ultrasound


. 2020 Aug 18.
doi: 10.1007/s40477-020-00515-1. Online ahead of print.
Early detection of deep vein thrombosis in patients with coronavirus disease 2019: who to screen and who not to with Doppler ultrasound?


Anna Maria Ierardi[SUP] 1 [/SUP], Andrea Coppola[SUP] 2 [/SUP], Stefano Fusco[SUP] 3 [/SUP], Elvira Stellato[SUP] 3 [/SUP], Stefano Aliberti[SUP] 4 5 [/SUP], Maria Carmela Andrisani[SUP] 3 [/SUP], Valentina Vespro[SUP] 3 [/SUP], Antonio Arrichiello[SUP] 3 [/SUP], Mauro Panigada[SUP] 6 [/SUP], Valter Monzani[SUP] 7 [/SUP], Giacomo Grasselli[SUP] 6 5 [/SUP], Massimo Venturini[SUP] 2 [/SUP], Bhavya Rehani[SUP] 8 [/SUP], Flora Peyvandi[SUP] 9 5 [/SUP], Antonio Pesenti[SUP] 6 5 [/SUP], Francesco Blasi[SUP] 4 5 [/SUP], Gianpaolo Carrafiello[SUP] 3 10 [/SUP]



Affiliations

Abstract

Purpose: Aim of the study is to evaluate the incidence of DVT in COVID-19 patients and its correlation with the severity of the disease and with clinical and laboratory findings.
Methods: 234 symptomatic patients with COVID-19, diagnosed according to the World Health Organization guidelines, were included in the study. The severity of the disease was classified as moderate, severe and critical. Doppler ultrasound (DUS) was performed in all patients. DUS findings, clinical, laboratory's and therapeutic variables were investigated by contingency tables, Pearson chi square test and by Student t test and Fisher's exact test. ROC curve analysis was applied to study significant continuous variables.
Results: Overall incidence of DVT was 10.7% (25/234): 1.6% (1/60) among moderate cases, 13.8% (24/174) in severely and critically ill patients. Prolonged bedrest and intensive care unit admission were significantly associated with the presence of DVT (19.7%). Fraction of inspired oxygen, P/F ratio, respiratory rate, heparin administration, D-dimer, IL-6, ferritin and CRP showed correlation with DVT.
Conclusion: DUS may be considered a useful and valid tool for early identification of DVT. In less severely affected patients, DUS as screening of DVT might be unnecessary. High rate of DVT found in severe patients and its correlation with respiratory parameters and some significant laboratory findings suggests that these can be used as a screening tool for patients who should be getting DUS.

Keywords: COVID-19; Doppler; diagnosis; Pandemics; Ultrasonography; Venous thrombosis.
 
Back
Top Bottom